Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Apr;73(7):1383-5.
doi: 10.1007/s00018-016-2141-1. Epub 2016 Feb 3.

Parkinson's disease: towards better preclinical models and personalized treatments

Dan Lindholm  1   2 , Johanna Mäkelä  3   4 , Valentina Di Liberto  5 , Giuseppa Mudò  5 , Natale Belluardo  5 , Ove Eriksson  3 , Mart Saarma  6
Affiliations
Comment

Parkinson's disease: towards better preclinical models and personalized treatments

Dan Lindholm et al. Cell Mol Life Sci. 2016 Apr.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Segura-Aguilar J, Paris I, Muñoz P (2015) The need of a new and more physiological preclinical model for Parkinson´s disease. Cell Mol Life Sci - PMC - PubMed
    1. Lindholm D, Mäkelä J, Di Liberto V, Mudò G, Belluardo N, Eriksson O, Saarma M (2015) Current disease modifying approaches to treat Parkinson’s disease. Cell Mol Life Sci. 2015 Nov 30 (epub ahead of print) - PMC - PubMed
    1. Fahn S. Parkinson’s disease: 10 years of progress, 1997–2007. Mov Disord. 2010;25:S2–S14. doi: 10.1002/mds.22796. - DOI - PubMed
    1. Kalia LV, Kalia SK, Lang AE. Disease-modifying strategies for Parkinson’s disease. Mov Disord. 2015;30:1442–1450. doi: 10.1002/mds.26354. - DOI - PubMed
    1. Domanskyi A, Saarma M, Airavaara M. Prospects of neurotrophic factors for parkinson’s disease: comparison of protein and gene therapy. Hum Gene Ther. 2015;26:550–559. doi: 10.1089/hum.2015.065. - DOI - PubMed

Substances